Filter
2399
Filtered Results: 2399
Text search:
Word
Health
Organization
Featured
Recommendations
236
New Publications
344
Language
Document type
No document type
811
Studies & Reports
599
Guidelines
475
Manuals
215
Strategic & Response Plan
118
Training Material
93
Fact sheets
53
Situation Updates
11
Resource Platforms
9
Infographics
7
Brochures
6
App
1
Online Courses
1
Countries / Regions
Global
159
India
62
Kenya
56
South Africa
46
Russia
37
Western and Central Europe
36
Africa
33
Ethiopia
33
Syria
30
Uganda
29
Ukraine
28
Sierra Leone
25
Liberia
25
Tanzania
22
South–East Asia Region
21
Latin America and the Carribbean
20
Middle East and North Africa
20
Nepal
19
Nigeria
19
Bangladesh
18
Myanmar / Burma
18
Eastern Europe and Central Asia
17
Ghana
16
Malawi
16
Philippines
16
Burkina Faso
14
Mozambique
14
Zambia
14
Eastern Europe
13
Brazil
13
Rwanda
12
Senegal
12
East and Southern Africa
12
Congo, Democratic Republic of
11
Western Pacific Region
11
Yemen
11
Namibia
10
Indonesia
10
Cameroon
9
Guinea
9
Cambodia
9
Botswana
9
South Sudan
9
West and Central Africa
8
Lesotho
7
Zimbabwe
7
Asia
7
Pakistan
7
Benin
6
Germany
6
Colombia
5
Moldova
5
Kazakhstan
4
Kyrgyzstan
4
Vietnam
4
Sri Lanka
4
Sudan
4
Angola
4
Eswatini/ Swaziland
4
Tajikistan
3
China
3
Laos
3
Peru
3
Haiti
3
Guinea-Bissau
3
North America
3
United Kingdom
3
Papua New Guinea
3
Romania
3
Palestine
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Mexico
2
Niger
2
Afghanistan
2
Mongolia
2
USA
2
Paraguay
2
Gabon
2
Turkmenistan
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Poland
2
Iraq
2
Madagascar
2
Switzerland
1
Thailand
1
El Salvador
1
Serbia
1
Turkey
1
Iran
1
Canada
1
Fiji
1
Estonia
1
Uzbekistan
1
Burundi
1
Malaysia
1
Morocco
1
Qatar
1
Armenia
1
Saudi Arabia
1
Japan
1
Mauritius
1
Tunisia
1
Bolivia
1
Argentina
1
Lebanon
1
Georgia
1
Honduras
1
Mali
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
621
Clinical Guidelines
205
Public Health
182
Women & Child Health
178
Key Resources
161
Capacity Building
83
Pharmacy & Technologies
32
Toolboxes
COVID-19
289
Mental Health
198
HIV
144
NTDs
130
Caregiver
120
Disability
117
Planetary Health
97
AMR
97
TB
95
Pharmacy
70
Conflict
68
NCDs
63
Rapid Response
51
Global Health Education
46
Refugee
42
Health Financing Toolbox
41
Malaria
40
Ebola & Marburg
39
Social Ethics
36
Natural Hazards
19
2.0 Rapid Response
19
Cholera
15
Specific Hazards
12
Zika
8
Polio
4
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
his document, a first of its kind, clearly sets out the standards for rehabilitation and provides guidance on building or strengthening the capacity of EMTs in this area.The importance of early rehabilitation for functional outcomes is well documented. Rehabilitation needs can pe...
In January 2021, the World Health Organization (WHO) published a new road map to address the burden of disease and death imposed by neglected tropical diseases (NTDs). The end of the first year of the 2021-2030 NTD road map is an opportunity to take stock of where we stand and how we plan to move fo...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Временные рекомендации
13 марта 2020 г.
Настоящий документ является вторым изданием руководства (версия 1.2), которое первоначально представляло собой адаптированн...
WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.
3 August 2021- Gatherings are events characterized by the concentration of people at a specific location for a specific purpose over a set period of time.
The aim of this policy brief is to present WHO’s position on, and guidance in relation to, holding gatherings during the COVID-19 pandemic. It...
Web annex 6: Injectable prostaglandins versus
placebo or no treatment
Evidence to Decision Framework
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
Today, patient harm due to unsafe care is a large and growing global public health challenge and is one of the
leading causes of death and disability worldwide. Most of this patient harm is avoidable. As countries strive to
achieve universal health coverage and the Sustainable Development Goals, t...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
The combined effects from ambient (outdoor) air pollution and indoor (household, in particular) air pollution cause approximately 7 million premature deaths every year, largely as a result of increased mortality from stroke, IHD, COPD, lung cancer and acute respiratory infections (1). Air pollution ...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
